The current price is in 1,49$, Cumberland Pharmaceuticals Inc, with address at 2525 WEST END AVENUE SUITE 950, NASHVILLE, Tennessee, 37203, United States, is a publicly traded company and its visible heads at the moment are A. J. Kazimi (Chairman & Chief Executive Officer), John Hamm (Chief Financial & Accounting Officer), Leo B. Pavliv (Chief Development Officer & EVP-Operations). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
Today this action begins with yesterday's closing price, desconocido$.
With an intraday difference of 1,47$ moving between 1,42$ and 1,51$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The last registered opening is of desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
